✦ LIBER ✦

A complete deletion of the factor IX gene and newTaqI variant in a hemophilia B kindred

✍ Scribed by S. A. M. Taylor; D. P. Lillicrap; V. Blanchette; A. R. Giles; J. J. A. Holden; B. N. White

Publisher: Springer
Year: 1988
Tongue: English
Weight: 630 KB
Volume: 79
Category: Article
ISSN: 0340-6717
DOI: 10.1007/bf00366250

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Line 1 insertion in the Factor IX gene

A Line 1 insertion in the Factor IX gene segregates with mild hemophilia B in dogs

✍ MarjoryB. Brooks; Weikuan Gu; JenniferL. Barnas; Jharna Ray; Kunal Ray 📂 Article 📅 2003 🏛 Springer-Verlag 🌐 English ⚖ 249 KB

Restriction endonuclease mapping of six

Restriction endonuclease mapping of six novel deletions of the factor VIII gene in hemophilia A

✍ Hagop Youssoufian; Carol K. Kasper; Deborah G. Phillips; Haig H. Kazazian; Styli 📂 Article 📅 1988 🏛 Springer 🌐 English ⚖ 572 KB

Mutations of the factor VIII gene in Tha

Mutations of the factor VIII gene in Thai hemophilia A patients

✍ V. Akkarapatumwong; S. Oranwiroon; P. Pung-amritt; A. Treesucon; P. Thanootaraku 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 121 KB 👁 2 views

Hemophilia A is a common X-linked bleeding disorder caused by mutations in the coagulation factor VIII gene. The entire coding and essential sequences of the factor VIII gene were generated by a combination of genomic DNA amplification and long reverse transcription-polymerase chain reaction (long R

CG dinucleotide transitions in the facto

CG dinucleotide transitions in the factor IX gene account for about half of the point mutations in hemophilia B patients: a Seattle series

✍ Shi-Han Chen; Min Zhang; Everett W. Lovrien; C. Ronald Scott; Arthur R. Thompson 📂 Article 📅 1991 🏛 Springer 🌐 English ⚖ 736 KB

Hemophilia B is due to multiple molecular defects in the factor IX gene. Over 80% of mutations are single base substitutions. By amplification and direct sequencing, 51 single base substitutions were found in the transcribed sequence of the factor IX genes of patients from 50 distinct families with

In vivo recovery and half-life time of a

In vivo recovery and half-life time of a steam-treated factor IX concentrate in hemophilia B patients

✍ K�hler, M. ;Seifried, E. ;Hellstern, P. ;Pindur, G. ;Miyashita, C. ;M�rsdorf, S. 📂 Article 📅 1988 🏛 Springer-Verlag ⚖ 520 KB

Factor IX (FIX) recovery and half-life was measured in ten hemophilia B patients under standardized conditions. Each patient received a steam-treated high-purity factor IX concentrate at a dose of 19-39 U/kg body weight. FIX activity was determined using a one-stage assay, which was calibrated again

A common G10430A mutation (Gly 60 Ser) i

A common G10430A mutation (Gly 60 Ser) in the factor IX gene describes the presence of moderate and mild hemophilia B in the majority of the Gujarati population

✍ Leera Quadros; Kanjaksha Ghosh; Shrimati Shetty 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 116 KB